105 related articles for article (PubMed ID: 1466260)
1. Dynamics of kallikrein activity in different biological fluids of pregnant animals.
Helili K; Somlev B; Karcheva V
Agents Actions Suppl; 1992; 38 ( Pt 1)():114-20. PubMed ID: 1466260
[TBL] [Abstract][Full Text] [Related]
2. Immunoassays for the determination of human tissue kallikrein (TK) in different body fluids based on monoclonal antibodies.
Witzgall K; Godec G; Shimamoto K; Fink E
Agents Actions Suppl; 1992; 38 ( Pt 1)():153-8. PubMed ID: 1466266
[TBL] [Abstract][Full Text] [Related]
3. Development and characterization of a radioimmunoassay to measure human tissue kallikrein in biological fluids.
Bagshaw AF; Bhoola KD; Lemon MJ; Whicher JT
J Endocrinol; 1984 May; 101(2):173-9. PubMed ID: 6562157
[TBL] [Abstract][Full Text] [Related]
4. Assaying plasma prekallikrein (PPK) by a chromogenic based method: analytical considerations and reference values in healthy adults, the pregnant woman, and the neonate.
Ito R; Statland BE; Sher G; Knutzen V
Adv Exp Med Biol; 1983; 156():205-23. PubMed ID: 6552838
[TBL] [Abstract][Full Text] [Related]
5. The assay of glandular kallikrein and prekallikrein in human mixed saliva.
Jenzano JW; Coffey JC; Heizer WD; Lundblad RL; Scicli AG
Arch Oral Biol; 1988; 33(9):641-4. PubMed ID: 3245788
[TBL] [Abstract][Full Text] [Related]
6. Biological assay for tissue kallikrein: comparison with the synthetic substrate S2266.
Campbell SK; Marshall KG; Millar JG; Raman GV; Albano JD
Agents Actions Suppl; 1992; 38 ( Pt 1)():159-65. PubMed ID: 1466267
[TBL] [Abstract][Full Text] [Related]
7. Centrifugal analysis for plasma kallikrein activity, with use of the chromogenic substrate S-2302.
Ito R; Statland BE
Clin Chem; 1981 Apr; 27(4):586-93. PubMed ID: 6907061
[TBL] [Abstract][Full Text] [Related]
8. Glandular kallikrein levels in the rat anterior pituitary during the estrous cycle and pregnancy.
Powers CA; Westlin WF
Biol Reprod; 1987 Sep; 37(2):306-10. PubMed ID: 3676389
[TBL] [Abstract][Full Text] [Related]
9. Methods for the determination of glandular kallikrein by means of a chromogenic tripeptide substrate.
Amundsen E; Putter J; Friberger P; Knos M; Larsbraten M; Claeson G
Adv Exp Med Biol; 1979; 120A():83-95. PubMed ID: 495341
[TBL] [Abstract][Full Text] [Related]
10. Measurement of kallikrein activity in urine of rats and man using a chromogenic tripeptide substrate. Validation of the amidolytic assay by means of bradykinin radioimmunoassay.
Bönner G; Marin-Grez M
J Clin Chem Clin Biochem; 1981 Mar; 19(3):165-8. PubMed ID: 6908912
[TBL] [Abstract][Full Text] [Related]
11. [A substrate inhibitor analysis of the urinary excretion of tissue and plasma kallikreins in patients with chronic glomerulonephritis].
Platonova LV; Poliantseva LR; Filatova MP; Paskhina TS
Urol Nefrol (Mosk); 1990; (4):38-43. PubMed ID: 2275058
[TBL] [Abstract][Full Text] [Related]
12. A novel chromogenic peptide for prekallikrein/kallikrein determination.
Huang WY; Wan X; Zhang S
Clin Lab; 2009; 55(3-4):106-13. PubMed ID: 19462932
[TBL] [Abstract][Full Text] [Related]
13. Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein "like" activity in human plasma.
Gallimore MJ; Friberger P
Thromb Res; 1982 Feb; 25(3):293-8. PubMed ID: 6917564
[No Abstract] [Full Text] [Related]
14. Chromogenic peptide substrate assays for determining components of the plasma kallikrein system.
Gallimore MJ
Scand J Clin Lab Invest Suppl; 1985; 178():127-32. PubMed ID: 3867113
[TBL] [Abstract][Full Text] [Related]
15. [Use of chromogenic substrates for estimation of indicators of kallikrein-kinin and blood coagulation systems in blood plasma of patients with nephrotic syndrome].
Baskova IP; Paskhina TS; Poliantseva LR; Iakubovskaia RI; Tiero A
Vopr Med Khim; 1983; 29(5):96-9. PubMed ID: 6557709
[TBL] [Abstract][Full Text] [Related]
16. The presence of glandular kallikrein in rabbit fetal placental conditioned medium.
Weerasinghe KM; Gadsby JE
Endocrinology; 1992 Oct; 131(4):1777-81. PubMed ID: 1396322
[TBL] [Abstract][Full Text] [Related]
17. Formation of an association between factor XII and kallikrein in human plasma--significance of storage of plasma and the functional state of plasma kallikrein.
Hoem NO; Johannesen S; Briseid K
Thromb Res; 1992 May; 66(4):421-34. PubMed ID: 1412207
[TBL] [Abstract][Full Text] [Related]
18. Prekallikrein activation in human, bovine, and rabbit plasmas: presence of an inhibitor in bovine plasma.
Weerasinghe KM
Inflammation; 1992 Jun; 16(3):205-13. PubMed ID: 1500097
[TBL] [Abstract][Full Text] [Related]
19. Circulating levels of prekallikrein and kallikrein in pregnancy and labor.
Sayama S; Kashiwagi H; Ogawa T; Terada K; Soma H; Kato M
Int J Biol Res Pregnancy; 1981; 2(2):90-4. PubMed ID: 6916725
[TBL] [Abstract][Full Text] [Related]
20. [The use of a tripeptide chromogenic substrate for simultaneous determination of 4 indices of kallikrein-kinin system].
Dotsenko VL; Iarovaia GA; Neshkova EA
Vopr Med Khim; 1989; 35(2):128-33. PubMed ID: 2741408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
